The RNA Analysis/ Transcriptomics Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions - Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).
Learn More On The RNA Analysis/ Transcriptomics Market:
https://www.thebusinessresearchcompany.com/report/rna-analysis-transcriptomics-global-market-report
According to The Business Research Company’s RNA Analysis/ Transcriptomics Global Market Report 2024, The rna analysis/ transcriptomics market size has grown rapidly in recent years. It will grow from $6.89 billion in 2023 to $7.91 billion in 2024 at a compound annual growth rate (CAGR) of 14.9%. The growth in the historic period can be attributed to cancer research and precision medicine, drug discovery and development, infectious disease diagnostics, personalized medicine, academic and government funding, growing applications in agriculture..
The rna analysis/ transcriptomics market size is expected to see rapid growth in the next few years. It will grow to $14.2 billion in 2028 at a compound annual growth rate (CAGR) of 15.7%. The growth in the forecast period can be attributed to single-cell rna sequencing applications, integration of rna analysis in clinical diagnostics, rna-based therapies and vaccines, bioinformatics and data analysis tools, biomarker discovery and validation.. Major trends in the forecast period include spatial transcriptomics and in situ rna analysis, long-read rna sequencing technologies, rna editing and modification analysis, integration of ai in rna data analysis, rna therapeutics for rare diseases, rna-based liquid biopsy for cancer detection..
The increasing demand for personalized medicine is expected to drive the growth of the RNA analysis/ transcriptomics market in the coming years. Personalized medicine refers to the customizing of medical treatment to each patient's unique characteristics. If scientists can implement the necessary practices and processes for personalized clinical care, RNA-Seq will be well-positioned to handle the massive clinical workload. For instance, in October 2022, according to the Personalized Medicine Coalition (PMC), a US-based organization that promotes understanding and adoption of personalized medicine, more than 75,000 genetic testing products and 300 personalized medicines will be on the market for people with multiple types of cancer, genetic rare diseases, and a range of chronic and infectious diseases. Therefore, the growing demand for personalized medicines propels the growth of the RNA analysis market.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=5241&type=smp
The rna analysis/ transcriptomics market covered in this report is segmented –
1) By Product: Reagents/Consumables, Instruments, Software
2) By Technology: Microarrays, Sequencing, Polymerase Chain Reaction RNA Interference
3) By Application: Clinical Diagnostics, Drug Discovery, Toxicogenomics, Comparative Transcriptomics, RNA Interference
Top Major Players
Affymetrix Inc.
Agilent Technologies Inc.
Bio-Rad Laboratories Inc.
GE Healthcar
Illumina Inc.
Technological advancements and innovations in RNA analysis are an emerging trend in the RNA analysis/ transcriptomics market. Technologies such as next-generation sequencing (NGS) and RNA interference (RNAi) improved precision and accuracy, which help researchers analyze the transcriptional activity. For instance, Next-generation sequencing developed by Illumina is successfully used in fragmenting DNA/RNA into multiple pieces, adding adapters, sequencing the libraries, and reassembling them to form a genomic sequence.
The rna analysis/ transcriptomics market report table of contents includes:
1. Executive Summary
2. RNA Analysis/ Transcriptomics Market Characteristics
3. RNA Analysis/ Transcriptomics Market Trends And Strategies
4. RNA Analysis/ Transcriptomics Market - Macro Economic Scenario
5. Global RNA Analysis/ Transcriptomics Market Size and Growth
.............................
31. Global RNA Analysis/ Transcriptomics Market Competitive Benchmarking
32. Global RNA Analysis/ Transcriptomics Market Competitive Dashboard
33. Key Mergers And Acquisitions In The RNA Analysis/ Transcriptomics Market
34. RNA Analysis/ Transcriptomics Market Future Outlook and Potential Analysis
35. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
RNA sequencing is a prevailing research tool for transcriptomics research, which uses next-generation sequencing technology to provide information about the transcription of an organism rapidly and accurately, revealing the gene expression of an organism.
In recent years, this method has become very popular in biological sciences and medical research, and its use is gradually moving towards clinical applications.
When studying the events as bacteria infect the host, most focus on either bacterial or host mRNA.
It labels the bacteria with fluorescence, enabling the identification of the infected host cell components.
This technique allows the study of mRNAs and transcripts of non-coding RNAs from both organisms as the course of the infection progresses.
A full dual RNA-Seq test comprises three phases: (1) total host-bacteria RNA extraction and purification; (2) total RNA next-generation sequencing (NGS); and (3) bioinformatic processing and statistical analysis of the host-bacteria transcriptome.
